Ascendis Pharma A ASND
NASDAQ ASND
$228.07 -1.98 (-0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Payables (2012 - 2026)

Updated

Ascendis Pharma A (ASND) posted Payables of $120.79 million for the quarter ended Jun 30, 2026, up 13.9% from $106.08 million a year earlier but down 77.8% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Payables (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A's Payables came in at $102.43 million, down 1.8% from the prior year.

  • Annual Payables shows a five-year compound annual growth rate of 31.4% (years ended Dec 2020 to Dec 2025).
  • In prior years, Ascendis Pharma A's Payables was $104.33 million in the year ended Dec 31, 2024 (+2.0%), $102.29 million in the year ended Dec 31, 2023 (-3.9%), $106.48 million in the year ended Dec 31, 2022 (+56.7%) and $67.97 million in the year ended Dec 31, 2021 (+160.4%).
  • Quarterly Payables has run from a low of $67.97 million in the quarter ended Dec 31, 2021 to a high of $544.04 million in the quarter ended Mar 31, 2026 over five years.
  • On a year-over-year basis, Payables has increased in each of the last four quarters, with growth averaging 61.2% over the last eight quarters.
  • The strongest year-over-year quarter for Payables in the past five years was the quarter ended Mar 31, 2026, with growth of 513.0%; the weakest was the quarter ended Sep 30, 2024, with a decline of 37.5%.
  • According to Business Quant data, Payables for the three prior quarters was $544.04 million (quarter ended Mar 31, 2026), $105.53 million (quarter ended Dec 31, 2025) and $91.89 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 20.92 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 5.96 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 7.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Ascendis Pharma A 14.26 Bn 10.50 Bn 362.22 Mn 120.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.79 Mn
Mar 31, 2026 544.04 Mn
Dec 31, 2025 105.53 Mn
Sep 30, 2025 91.89 Mn
Jun 30, 2025 106.08 Mn
Mar 31, 2025 88.75 Mn
Dec 31, 2024 103.01 Mn
Sep 30, 2024 82.66 Mn
Jun 30, 2024 107.18 Mn
Mar 31, 2024 102.69 Mn
Dec 31, 2023 101.75 Mn
Sep 30, 2023 132.32 Mn
Jun 30, 2023 132.98 Mn
Mar 31, 2023 141.08 Mn
Dec 31, 2022 103.08 Mn
Sep 30, 2022 86.81 Mn
Jun 30, 2022 80.01 Mn
Mar 31, 2022 79.33 Mn
Dec 31, 2021 67.97 Mn
Sep 30, 2021 90.18 Mn
API Access

Ascendis Pharma A Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=ASND&period=max&api_key=YOUR_API_KEY